Security key
92243G108
Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX)
CUSIP: 92243G108
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 145,782,011
- Total 13F shares
- 162,525,674
- Share change
- +12,752,342
- Total reported value
- $9,435,684,462
- Put/Call ratio
- 165%
- Reported price per share
- $58.11
- Number of holders
- 334
- Value change
- +$770,401,520
- Number of buys
- 189
- Number of sells
- 104
Security identity
2 facts
Holder snapshot
9 facts
Report period
Q1 2026
Institutions
334
Top holders
10
PCVX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Vaxcyte, Inc. SEC filings
Vaxcyte, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92243G108
Recent filing periods:
Ownership snapshot
Top reported holders of PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
JANUS HENDERSON GROUP PLC
13D/G signal
JANUS HENDERSON GROUP PLC
Evidence rows
15
Latest as of
31 Mar 2026
13D/G
13F
Lead comparable stake: 12%
13D/G row: JANUS HENDERSON GROUP PLC
Showing 1-6 of 15 holder rows.
Rank 1 holder
JANUS HENDERSON GROUP PLC
13D/G
13F
- Ownership
- 12%
- Position
- $1.02B
Rank 2 holder
FMR LLC
13D/G
13F
- Ownership
- 11%
- Position
- $1.02B
Rank 3 holder
RA CAPITAL MANAGEMENT, L.P.
13D/G
13F
- Ownership
- 8.9%
- Position
- $801.18M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
Company
|
12%
|
$1,023,560,281
16,575,875 shares
|
+$214,375,746 | 31 Mar 2026 |
| FMR LLC |
13D/G
13F
Company
|
11%
|
$1,015,853,037
16,451,061 shares
|
+$204,901,073 | 31 Mar 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
Company
|
8.9%
|
$801,181,488
12,974,599 shares
|
+$624,169 | 31 Mar 2026 |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
Company
|
8.6%
from 13D/G
|
$521,213,000
11,296,333 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.6%
from 13D/G
|
$472,767,877
10,246,378 shares
|
— | 31 Dec 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
Vanguard Capital Management
|
5%
|
$421,416,800
7,252,053 shares
|
$0 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
334
Shares
162,525,674
Rows available
334
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
293
Q1 2026 holders
334
Holder diff
41
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend